Lee's Pharmaceutical Holdings Limited (HKG:0950)
Hong Kong · Delayed Price · Currency is HKD 1.210
+0.075 (6.61%)
Sep 18, 2026, 3:57 PM HKT
HKG:0950 Financials Overview
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,538 | 1,436 | 1,400 | 1,053 | 1,233 | 1,266 |
Revenue Growth | 7.08% | 2.57% | 32.95% | -14.61% | -2.61% | 4.06% |
Gross Profit Gross Profit Growth | 816.96 | 729.56 | 753.36 | 551.31 | 770.76 | 806.28 |
Operating Income Operating Income Growth | 128.67 | 110.28 | 133.55 | 36.04 | 127.44 | -95.13 |
Net Income Net Income Growth | 119.77 | 91.94 | 93.1 | 16.7 | 51.28 | 1,987 |
Earnings Per Share EPS Growth | 0.20 | 0.16 | 0.16 | 0.03 | 0.09 | 3.37 |
EPS Growth | 30.23% | -1.26% | 457.53% | -67.44% | -97.42% | 1434.25% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Licensed-In Products Licensed-In Products Growth | 630.39 | 564.34 | 553.24 | 467.28 | 733.34 | 749.14 |
Proprietary and Generic Products Proprietary and Generic Products Growth | 907.34 | 871.65 | 846.73 | 585.76 | 499.81 | 517.02 |
Total Total Growth | 1,538 | 1,436 | 1,400 | 1,053 | 1,233 | 1,266 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 364.39 | 349.9 | 216.85 | 171 | 189.3 | 277.53 |
Total Debt Total Debt Growth | 249.84 | 310.27 | 227.3 | 204.14 | 163.49 | 267.14 |
Net Cash (Debt) Net Cash Growth | 114.55 | 39.63 | -10.45 | -33.14 | 25.81 | 10.39 |
Net Cash Growth | 189.06% | - | - | - | 148.36% | -95.97% |
Net Cash Per Share Net Cash Per Share Growth | 0.19 | 0.07 | -0.02 | -0.06 | 0.04 | 0.02 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 383.15 | 332.9 | 242.01 | 110.08 | 283.63 | 210.68 |
Capital Expenditures CapEx Growth | -109.44 | -66.63 | -43.96 | -29.43 | -17.46 | -50.7 |
Free Cash Flow Free Cash Flow Growth | 273.71 | 266.27 | 198.06 | 80.65 | 266.18 | 159.99 |
Free Cash Flow Growth | 2.79% | 34.44% | 145.58% | -69.70% | 66.37% | 98.70% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 53.13% | 50.81% | 53.81% | 52.35% | 62.50% | 63.68% |
Operating Margin | 8.37% | 7.68% | 9.54% | 3.42% | 10.33% | -7.51% |
Pretax Margin | 6.42% | 5.08% | 7.01% | 2.92% | 5.50% | 155.54% |
Profit Margin | 7.79% | 6.40% | 6.65% | 1.59% | 4.16% | 156.94% |
FCF Margin | 17.80% | 18.54% | 14.15% | 7.66% | 21.58% | 12.64% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.045 | 0.045 | 0.045 | 0.018 | 0.020 | 0.061 |
Dividend Per Share Growth | 23.40% | 0% | 150.00% | -10.00% | -67.21% | 5.17% |
Dividend Yield | 3.72% | 3.03% | 3.33% | 1.27% | 1.34% | 2.05% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 5.95 | 9.74 | 8.98 | 53.95 | 18.72 | 0.99 |
Forward PE | - | 8.46 | 8.46 | 10.89 | 8.15 | 10.41 |
P/FCF Ratio | 2.60 | 3.36 | 4.22 | 11.17 | 3.61 | 12.26 |
PS Ratio | 0.46 | 0.62 | 0.60 | 0.86 | 0.78 | 1.55 |